SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Corixa [CRXA] - cancer vaccines
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Pseudo Biologist who wrote (66)3/20/2001 3:36:31 PM
From: Biomaven  Read Replies (2) of 222
 
I do recall Rick raising early questions as to the comparative efficacy of the hot antibody and the cold antibody, and the company being fairly evasive on the issue.

One other warning sign in retrospect was the European Bexxar rights - when those were waived it was a wake-up call that we all apparently slept right through.

Finally, when we never got a good explanation of the "reformatting" fiasco, we should have been out of the stock.

So there were indeed some warning signs - the trouble is they were stacked up against very good clinical results.

I exited my final tranche last week, just missing this final debacle.

Peter
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News